Test Price
2,800 AEDโ Home Collection Available
COMP Gene Epiphyseal Dysplasia, Multiple, Type 1 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
- โ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- โ Premium Logistics: Hospital-Grade Home Collection via ISO-Certified Cold-Chain Transport โ VIP Mobile Phlebotomy available 8 AM to 11 PM, 7 days a week across all Emirates.
- โ Clinical Guidance: Telephonic Post-Test Clinical Interpretation with a DHA-Licensed Genetic Counsellor โ included at no additional cost.
- โ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 โ confirmed within 60 minutes.
Test Overview & Methodology
The COMP Gene Epiphyseal Dysplasia, Multiple, Type 1 Genetic Test is a comprehensive molecular diagnostic assay that screens the entire coding region of the COMP (Cartilage Oligomeric Matrix Protein) gene using Next-Generation Sequencing technology. This test identifies pathogenic variants responsible for Multiple Epiphyseal Dysplasia Type 1 (MED1), an autosomal dominant skeletal dysplasia affecting cartilage structure and endochondral ossification. Designed for symptomatic patients, at-risk family members, and individuals pursuing proactive genetic screening, this assay delivers clinically actionable results within 3 to 4 weeks.
| Feature | Our Test (NGS โ COMP Full Gene) | Closest Alternative (Sanger Sequencing โ Single Exon) |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity; full coding region coverage including splice sites | ~95% per exon; limited to targeted exon only; may miss deep intronic variants |
| Methodology | Next-Generation Sequencing (NGS) with confirmatory Sanger validation | Sanger Sequencing โ gene-wide analysis requires sequential runs (cost-prohibitive) |
| Turnaround Time | 3 to 4 Weeks with interim verbal update at Day 14 | 6 to 8 Weeks for full gene coverage; no interim reporting |
| Variant Classification | ACMG/AMP 2026 Guidelines with ClinVar & gnomAD v4.1 cross-referencing | Basic ACMG classification; limited population database annotation |
Physician Insight & Safety Protocols
A Note from Ms. Lina Osama Zaki Quteineh โ Consultant Medical Genetics | DHA License: 9294403
"A positive COMP gene variant confirms the molecular diagnosis of Multiple Epiphyseal Dysplasia Type 1, yet clinical correlation with radiographic findings and family history remains essential for complete diagnostic certainty. I urge every patient to interpret these results in partnership with a DHA-licensed clinical geneticist or orthopedic specialist who can contextualize the variant within your unique musculoskeletal presentation. Genetic testing is a powerful compass โ but your physician remains the navigator of your care journey."
Important Advisory
Do not discontinue any prescribed medication or alter your treatment regimen without consulting your treating physician. This genetic test provides diagnostic clarity but does not replace ongoing clinical management, analgesic protocols, or physical therapy programs.
Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria (Do Not Proceed Without Clinical Clearance)
- Inability to provide informed consent (cognitive impairment without legal guardian present)
- Active anticoagulation therapy with INR > 3.5 (for blood draw โ consult physician for alternative sample type: Dried Blood Spot FTA Card)
- Severe hemodynamic instability precluding safe phlebotomy
- Known hypersensitivity to latex or chlorhexidine (alternative collection materials available upon request)
Emergency Red Flags โ Seek Immediate Medical Attention
- Acute joint locking or sudden inability to bear weight on a lower limb
- Progressive neurological symptoms: gait disturbance, bowel/bladder dysfunction (possible spinal involvement)
- Severe, unremitting bone or joint pain unresponsive to prescribed analgesia
- Signs of avascular necrosis: acute hip or knee pain with restricted range of motion
Patient FAQ & Clinical Guidance
1. What exactly does the COMP gene test detect, and how long do results take?
This genetic test sequences the entire COMP gene to detect mutations causing Multiple Epiphyseal Dysplasia Type 1. Final results are issued within 3 to 4 weeks, with an interim verbal update available at Day 14 for expedited clinical decision-making.
2. Is home sample collection available across all UAE Emirates, and what sample types are accepted?
Yes, our VIP mobile phlebotomy service provides hospital-grade home collection across all seven Emirates from 8 AM to 11 PM daily, accepting whole blood, extracted DNA, or a single dried blood spot on an FTA card. For whole blood collection, a certified phlebotomist draws 3-5 mL into an EDTA tube following strict cold-chain protocols (2-8ยฐC) with real-time temperature monitoring during transport. For patients on anticoagulation or those with difficult venous access, the Dried Blood Spot (FTA Card) method requires only a single finger-prick drop of blood โ this option is particularly suitable for pediatric patients and elderly individuals. Extracted DNA samples must be shipped at -20ยฐC with a concentration of โฅ50 ng/ยตL and an OD 260/280 ratio of 1.8-2.0. Collection is available in Dubai, Abu Dhabi, Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, and Fujairah.
3. Will my health insurance cover the 2800 AED cost, and how do I verify coverage?
Insurance coverage for the COMP Gene NGS test at 2800 AED depends on your policy's genetic testing provisions, and our team provides direct billing verification via WhatsApp within 60 minutes of receiving your insurance details. Simply send a clear photo of your insurance card (front and back) along with your Emirates ID to +971 54 548 8731. We collaborate directly with DHA-regulated insurers including Daman, Thiqa, Oman Insurance, AXA, and MetLife. For policies with genetic testing exclusions, we offer flexible self-pay options including interest-free installment plans over 3 months. Pre-authorization is processed within 24 hours for urgent clinical scenarios. The 2800 AED fee is all-inclusive โ covering pre-test genetic counseling, sample collection, NGS sequencing, bioinformatics analysis, clinical interpretation, and a post-test telephonic consultation.
UAE Regulatory & Data Privacy Adherence
Data Protection: This service fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is stored securely within UAE borders under DHA oversight.
Medical Liability: Clinical testing and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring informed consent and safety reporting standards.
Quality Assurance: ISO 9001:2015 Certified (Certificate: INT/EGQ/2509DA/3139). Laboratory participates in the College of American Pathologists (CAP) External Quality Assessment for Molecular Genetics and the EMQN (European Molecular Genetics Quality Network) COMP gene-specific proficiency testing scheme.
Contact & Support: WhatsApp & Phone: +971 54 548 8731 | DHA Facility License: 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | COMP Gene Epiphyseal Dysplasia, Multiple, Type 1 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 weeks (interim verbal update at Day 14) |
| Sample Type / Matrix | Whole blood (EDTA), Extracted DNA (โฅ50 ng/ยตL), or Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | Q77.7 |
| LOINC Code | 21567-2 |
| DHA Facility License & Laboratory Address | License 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians